Hemoadsorption to improve organ recovery from brain-dead organ donors: A novel therapy for a novel indication?

Blood Purification

Volumn 22, Issue 1, 2004, Pages 143-149

  Venkataraman, Ramesh ^a   Song, Mingchen ^a   Lynas, Rachel ^a   Kellum, John A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Brain death, hemodynamic effects; Donors, brain dead; Graft survival; Hemodynamic instability; Organ recovery

Indexed keywords

CYTOKINE; PROTEIN S100B;

ALLOGRAFT; ARTICLE; BRAIN DEATH; BRAIN INJURY; DOWN REGULATION; GLIOBLASTOMA; HEMADSORPTION; HEMODYNAMIC MONITORING; HEMODYNAMICS; HOMEOSTASIS; HUMAN; IMMUNOGENICITY; IMMUNOLOGY; IN VITRO STUDY; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; NONHUMAN; ORGAN BLOOD FLOW; ORGAN DONOR; ORGAN INJURY; OXYGEN CONSUMPTION; PERFUSION PRESSURE; PRIORITY JOURNAL; PURIFICATION; REGIONAL PERFUSION; TREATMENT INDICATION;

BRAIN; BRAIN DEATH; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELLS, CULTURED; CYTOKINES; GLIOBLASTOMA; GRAFT REJECTION; GRAFT SURVIVAL; HEMOPERFUSION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; ISCHEMIA; NERVE GROWTH FACTORS; OXYGEN CONSUMPTION; S100 PROTEINS; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0942278981     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074935     Document Type: Article

References (62)

1. UNOS: 1996 Annual Report of the US Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network. Washington, US Department of Health and Human Services, 1996.
2. Kauffman HM, McBride MA, Rosendale JD, Ellison MD, Daily OP, Wolf JS: Trends in organ donation, recovery and disposition: UNOS data for 1988-1996. Transplant Proc 1997;29:3303-3304.
3. Mandal AK, Kalligonis AN, Ratner LE: Expanded criteria donors: Attempts to increase the renal transplant donor pool. Adv Ren Replace Ther 2000;7:117-130.
4. Busson M, Benoit G, N'Doye P, Hors J: Analysis of cadaver donor criteria on the kidney transplant survival rate in 5,129 transplantations. J Urol 1995;154:356-360.
5. Tullius SG, Nieminen M, Bechstein WO, Jonas S, Steinmuller T, Qun Y, Pratschke J, Graser E, Sinha P, Volk HD, Neuhaus P, Tilney NL: Contribution of early acute rejection episodes to chronic rejection in a rat kidney retransplantation model. Kidney Int 1998;53:465-472.
6. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S: High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995;333:333-336.
7. Busson M, N'Doye P, Benoit G, Hannoun L, Adam R, Pavie A, Romano P, Hors J: Donor factors influencing organ transplant prognosis. Transplant Proc 1995;27:1662-1664.
8. Pratschke J, Wilhelm MJ, Kusaka M, Basker M, Cooper DK, Hancock WW, Tilney NL: Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 1999;67:343-348.
9. Cecka JM: Outcome statistics of renal transplants with an emphasis on long-term survival. Clin Transpl 1994;8:324-327.
10. Cecka M: Clinical outcome of renal transplantation. Factors influencing patient and graft survival. Surg Clin North Am 1998;78:133-148.
11. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000;342:605-612.
12. Powner DJ, Hendrich A, Nyhuis A, Strate R: Changes in serum catecholamine levels in patients who are brain dead. J Heart Lung Transplant 1992;11:1046-1053.
13. Gramm HJ, Zimmermann J, Meinhold H, Dennhardt R, Voigt K: Hemodynamic responses to noxious stimuli in brain-dead organ donors. Intensive Care Med 1992;18:493-495.
14. Marshall VC: Pathophysiology of brain death: Effects on allograft function. Transplant Proc 2001;33:845-846.
15. Pratschke J, Wilhelm MJ, Kusaka M, Hancock WW, Tilney NL: Activation of proinflammatory genes in somatic organs as a consequence of brain death. Transplant Proc 1999;31:1003-1005.
16. Stangl M, Zerkaulen T, Theodorakis J, Illner W, Schneeberger H, Land W, Faist E: Influence of brain death on cytokine release in organ donors and renal transplants. Transplant Proc 2001;33:1284-1285.
17. Takada M, Nadeau KC, Hancock WW, Mackenzie HS, Shaw GD, Waaga AM, Chandraker A, Sayegh MH, Tilney NL: Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998;65:1533-1542.
18. Wilhelm MJ, Pratschke J, Beato F, Taal M, Kusaka M, Hancock WW, Tilney NL: Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation 2000;102:2426-2433.
19. Lopau K, Mark J, Schramm L, Heidbreder E, Wanner C: Hormonal changes in brain death and immune activation in the donor. Transpl Int 2000;13(suppl 1):S282-S285.
20. Plenz G, Eschert H, Erren M, Wichter T, Bohm M, Flesch M, Scheld HH, Deng MC: The interleukin-6/interleukin-6-receptor system is activated in donor hearts. J Am Coll Cardiol 2002;39:1508-1512.
21. Birks EJ, Burton PB, Owen V, Mullen AJ, Hunt D, Banner NR, Barton PJ, Yacoub MH: Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation 2000;102:352-358.
22. Deng MC, Erren M, Kammerling L, Gunther F, Kerber S, Fahrenkamp A, Assmann G, Breithardt G, Scheld HH: The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation. Transplantation 1995;60:1118-1124.
23. Finkel MS, Hoffman RA, Shen L, Oddis CV, Simmons RL, Hattler BG: Interleukin-6 (IL-6) as a mediator of stunned myocardium. Am J Cardiol 1993;71:1231-1232.
24. Kirklin JK, McGiffin DC: Control of the inflammatory response in extended myocardial preservation of the donor heart. Ann Thorac Surg 1999;68:1978-1982.
25. Birks EJ, Owen VJ, Burton PB, Bishop AE, Banner NR, Khaghani A, Polak JM, Yacoub MH: Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation. Circulation 2000;102:326-331.
26. Birks EJ, Yacoub MH, Burton PS, Owen V, Pomerance A, O'Halloran A, Banner NR, Khaghani A, Latif N: Activation of apoptotic and inflammatory pathways in dysfunctional donor hearts. Transplantation 2000;70:1498-1506.
27. Pratschke J, Kofla G, Wilhelm MJ, Vergopoulos A, Laskowski I, Shaw GD, Tullius SG, Volk HD, Neuhaus P, Tilney NL: Improvements in early behavior of rat kidney allografts after treatment of the brain-dead donor. Ann Surg 2001;234:732-740.
28. Novitzky D, Cooper DK, Reichart B: The value of hormonal therapy in improving organ viability in the transplant donor. Transplant Proc 1987;19:2037-2038.
29. Novitzky D, Cooper DK, Reichart B: Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 1987;43:852-854.
30. Novitzky D, Cooper DK, Chaffin JS, Greer AE, DeBault LE, Zuhdi N: Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation 1990;49:311-316.
31. Pennefather SH, Bullock RE, Mantle D, Dark JH: Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation 1995;59:58-62.
32. Koo DD, Welsh KI, McLaren AJ, Roake JA, Morris PJ, Fuggle SV: Cadaver versus living donor kidneys: Impact of donor factors on antigen induction before transplantation. Kidney Int 1999;56:1551-1559.
33. Passey RJ, Xu K, Hume DA, Geczy CL: S100A8: Emerging functions and regulation. J Leukoc Biol 1999;66:549-556.
34. Schafer BW, Heizmann CW: The S100 family of EF-hand calcium-binding proteins: Functions and pathology. Trends Biochem Sci 1996;21:134-140.
35. Li Y, Barger SW, Liu L, Mrak RE, Griffin WS: S100beta induction of the proinflammatory cytokine interleukin-6 in neurons. J Neurochem 2000;74:143-150.
36. Pratschke J, Wilhelm MJ, Kusaka M, Beato F, Milford EL, Hancock WW, Tilney NL: Accelerated rejection of renal allografts from brain-dead donors. Ann Surg 2000;232:263-271.
37. Galun E, Axelrod JH: The role of cytokines in liver failure and regeneration: Potential new molecular therapies. Biochim Biophys Acta 2002;1592:345-358.
38. Camargo CA Jr, Madden JF, Gao W, Selvan RS, Clavien PA: Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997;26:1513-1520.
39. Abraham E, Anzueto A, Gutierrez G, Tessler S, San Pedro G, Wunderink R, Dal Nogare A, Nasraway S, Berman S, Cooney R, Levy H, Baughman R, Rumbak M, Light RB, Poole L, Allred R, Constant J, Pennington J, Porter S: Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORA-SEPT II Study Group. Lancet 1998;351:929-933.
40. Fisher CJ Jr, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL: Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 1994;271:1836-1843.
41. Fisher CJ Jr, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E: Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 1996;334:1697-1702.
42. Adrie C, Pinsky MR: The inflammatory balance in human sepsis. Intensive Care Med 2000;26:364-375.
43. Kellum JA: Immunomodulation in sepsis: The role of hemofiltration. Minerva Anestesiol 1999;65:410-418.
44. Kellum JA, Venkataraman R: Blood purification in sepsis: An idea whose time has come? Crit Care Med 2002;30:1387-1388.
45. von Andrian UH, Mackay CR: T-cell function and migration. Two sides of the same coin. N Engl J Med 2000;343:1020-1034.
46. Silvester W: Mediator removal with CRRT: Complement and cytokines. Am J Kidney Dis 1997;30:38-43.
47. Cole L, Bellomo R, Hart G, Journois D, Davenport P, Tipping P, Ronco C: A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002;30:100-106.
48. Bellomo R, Kellum JA, Gandhi CR, Pinsky MR, Ondulik B: The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 2000;161:1429-1436.
49. Grootendorst AF, van Bommel EF, van der Hoven B, van Leengoed LA, van Osta AL: High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992;18:235-240.
50. Rogiers P, Zhang H, Smail N, Pauwels D, Vincent JL: Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 1999;27:1848-1855.
51. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P: High-volume haemofiltration in human septic shock. Intensive Care Med 2001;27:978-986.
52. Heering P, Morgera S, Schmitz FJ, Schmitz G, Willers R, Schultheiss HP, Strauer BE, Grabensee B: Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 1997;23:288-296.
53. Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hanique G, Matson JR: Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000;28:3581-3587.
54. Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF: Outcome of critically ill patients treated with intermittent high-volume haemofiltration: A prospective cohort analysis. Intensive Care Med 1999;25:814-821.
55. De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999;10:846-853.
56. Kellum JA, Dishart MK: Effect of hemofiltration filter adsorption on circulating IL-6 levels in septic rats. Crit Care 2002;6:429-433.
57. Winchester JF, Kellum JA, Ronco C, Brady JA, Quartararo PJ, Salsberg JA, Levin NW: Sorbents in acute renal failure and the systemic inflammatory response syndrome. Blood Purif 2003;21:79-84.
58. Pond SM: Extracorporeal techniques in the treatment of poisoned patients. Med J Aust 1991;154:617-622.
59. Ronco C, Brendolan A, Winchester JF, Golds E, Clemmer J, Polaschegg HD, Muller TE, Davankov V, Tsyurupa M, Pavlova L, Pavlov M, La Greca G, Levin NW: First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta 2-microglobulin in hemodialysis. Contrib Nephrol 2001;(133):166-173.
60. Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A, Dan M, Irone M, La Greca G, Inguaggiato P, Maggiore U, De Nitti C, Wratten ML, Ricci Z, Tetta C: A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002;30:1250-1255.
61. Song M, Kellum JA, Venkataraman R, Roberts G, Schmigel J: CytoSorb removes inflammatory mediators but not endotoxin in vitro (abstract). Crit Care Med 2003;31:A48.
62. Kellum JA, Song MC, Venkataraman R, Schmigel J, Statile C: Improved survival with hemoadsorption in endotoxin induced shock in rats. Am J Respir Crit Care Med 2002;165:A176.